Table 3.
Prevalence of HPV infection by clinical characteristics of study participants
| Characteristics | Categories | No. (%) screened | No. (%) positive | p |
|---|---|---|---|---|
| Parity | 0 | 19 (6.4) | 3 (15.8) | 0.456 |
| 1 | 32 (10.9) | 9 (28.1) | ||
| 2 | 49 (16.6) | 10 (20.4) | ||
| ≥3 | 189 (64.1) | 33 (17.5) | ||
| Post-menopausal age | 1-5 | 48 (16.3) | 8 (16.7) | 0.685 |
| 6-10 | 23 (7.8) | 3 (13.0) | ||
| ≥11 | 10 (3.3) | 3 (30.0) | ||
| Symptoms of STI | Yes | 121 (41.0) | 25 (20.7) | 0.458 |
| No | 174 (59.0) | 30 (17.2) | ||
| STI duration (years) | 1-10 | 111 (37.6) | 23 (20.7) | 0.970 |
| 11-20 | 5 (1.7) | 1 (20.0) | ||
| Long time | 5 (1.7) | 1 (20.0) | ||
| Genital warts | Yes | 24 (8.1) | 5 (20.8) | 0.774 |
| No | 271 (91.9) | 50 (18.5) | ||
| Ever had Pap smear | Yes | 72 (24.4) | 8 (11.1) | 0.059 |
| No | 223 (75.6) | 47 (21.1) | ||
| Cervical cancer screening result | Normal | 61 (20.7) 6 (9.8) | 0.063 | |
| LSIL | 9 (3.1) 1 (11.1) | |||
| HSIL | 1 (0.3) 0 (0.0) | |||
| Cervical cancer | 1 (0.3) | 1 (100.0) |
HPV: Human papillomavirus
LSIL: Low-grade Squamous Intraepithelial Lesion HSIL: High-grade Squamous Intraepithelial Lesion